DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.

THERANOSTICS. 2018, 8(8): 2278-2288.

Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.

Strahlenther Onkol. 2018, 194(7):62-637.

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.

LEUKEMIA. 2018, 32(7): 1621-1630.

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer.

Cancer Chemother Pharmacol. 2018.

Extensive leptomeningeal intracranial and spinal metastases in a patient with a supratentorial glioblastoma multiforme, IDH-wildtype: A case report.

World Neurosurg. 2018.

News from ASCO 2018.

BREAST CARE. 2018, 13(4): 298-302.

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.

Nat Commun. 2018, 9(1):1219.

Remission maintenance treatment options in chronic lymphocytic leukemia.

Cancer Treat Rev. 2018, 70:5-66.

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.

J Clin Oncol. 2018, 36(25):2603-2611.

Austrian recommendations for the management of polycythemia vera.

Wien Klin Wochenschr. 2018.